pharmaphorum40m
The critical bioanalytical strategies unlocking the potential of LNP-mRNA
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
Le Lézard41m
FDA Accepts Integral Molecular's Membrane Proteome Arraytm Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool
Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their Membrane Proteome Arraytm (MPA) Qualification Plan for advancement as a Drug ...
MyChesCo on MSN57m
Uvax Bio Appoints Kevin O’Neill as Interim CEO
Uvax Bio, LLC has announced the appointment of Kevin O’Neill as Interim Chief Executive Officer (CEO), succeeding company ...